Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin-collagen sponge for infected diabetic foot ulcer
2015-000934-31Phase 3Completed
- Sponsor
- Innocoll
- Start
- May 2015
- Modality
- Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Cogenzia in diabetic foot infection (DFI), Cutaneous ulcer and skin and soft tissue infections (SSTIs) (3 arms), sponsored by Innocoll. Primary endpoint: Clinical cure at Follow-up visit 1. Started May 2015; status: completed.
02
Drugs
Cogenzia
03
Conditions
diabetic foot infection (DFI)Cutaneous ulcerskin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on 2015-000934-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000934-31.